HER2 Negative Invasive Lobular Carcinoma
HER2 Negative Invasive Lobular Carcinoma HER2 negative invasive lobular carcinoma is a special kind of breast cancer. It doesn’t have the HER2 protein. This affects how we treat lobular breast cancer and the patient’s future.
We will look into the details of invasive lobular carcinoma her2 negative. We’ll talk about the best treatments for lobular carcinoma. This guide will help you understand how to manage this cancer type.
Introduction to HER2 Negative Invasive Lobular Carcinoma
Let’s talk about breast cancer types. HER2 negative breast cancer is a key type. It doesn’t have too much of the HER2 protein. This affects how we treat and predict outcomes.
Overview of HER2 Negative Breast Cancer
HER2 negative breast cancer means there’s not enough HER2 protein. About 70% of breast cancers are like this. They don’t work well with treatments like trastuzumab. Knowing about HER2 negative breast cancer helps doctors choose the right treatments.
What is Invasive Lobular Carcinoma?
Invasive lobular carcinoma (ILC) comes from the lobules, which make milk. It’s about 10-15% of breast cancers. ILC grows in a special way, hard to see on scans. It might react differently to treatments, so doctors need a special plan.
Symptoms of Lobular Carcinoma
Spotting lobular carcinoma early can really help. It’s key to know the signs and how they change. This helps in finding invasive lobular carcinoma early and getting the right treatment.
ACIBADEM Health Point: Your Health is Our Priority!
ACIBADEM Health Point, we are dedicated to providing exceptional healthcare services to our patients. With a team of highly skilled medical professionals and state-of-the-art facilities, we strive to deliver the highest standard of care to improve the health and well-being of our patients. What sets ACIBADEM Health Point apart is our patient-centered approach. We prioritize your comfort, safety, and satisfaction throughout your healthcare journey. Our compassionate staff ensures that you receive personalized care tailored to your unique needs, making your experience with us as seamless and comfortable as possible.Common Symptoms in Early Stages
Finding lobular carcinoma early depends on spotting its first signs. At the start, look out for:
- Subtle changes in breast texture
- A thickening or hardening in the breast tissue
- Unexplained pain in the breast
- Breast swelling that does not go away
- Skin changes or dimpling that feels odd
These early signs often don’t show up as lumps. So, it’s important to notice any small changes. They could be signs of lobular breast cancer.
Progression of Symptoms Over Time
As lobular carcinoma gets worse, symptoms get more obvious and hard to ignore. Keeping track of changes and seeing a doctor quickly is key. As it gets worse, women might see:
- More noticeable and ongoing breast pain
- Increased thickness and firmness in the breast
- Changes in breast shape or size
- Inverted nipples
- Swelling in the armpit area due to affected lymph nodes
Doctors stress the need to find lobular carcinoma early. This can lead to better treatments and outcomes. Doing self-exams and seeing a doctor regularly helps catch these signs early. This way, you can find invasive lobular carcinoma when it’s easier to treat.
Diagnosis of Invasive Lobular Carcinoma HER2 Negative
Getting an accurate invasive lobular carcinoma diagnosis takes a lot of tests and steps. It’s very important for planning treatment and helping patients get better.
Diagnostic Tests and Procedures
The first step in finding invasive lobular carcinoma HER2 negative is with breast cancer imaging. This includes:
- Mammography: Uses X-rays to find abnormal spots or changes in the breast.
- Ultrasound: Looks closer at any odd spots found in the breast with sound waves.
- MRI: Gives very clear pictures, especially in breasts that are hard to see through.
After imaging, a biopsy for lobular carcinoma is done to check for cancer cells. There are different ways to do this:
- Core Needle Biopsy: A big needle takes out a piece of breast tissue for tests.
- Fine Needle Aspiration: A thin needle gets cells from a strange area for looking at.
- Surgical Biopsy: Removes all or part of a suspicious area for closer checks.
Understanding Biopsy Results
The biopsy report tells us a lot about the cancer, like if it’s HER2 negative. This means the cancer doesn’t have too much HER2 protein or extra HER2 genes.
Understanding the biopsy results is important. Here’s what it means:
| Parameter | Description |
|---|---|
| HER2 Status | Shows if the cancer cells have too much HER2 protein or extra HER2 genes. |
| ER/PR Status | Tells us if the cancer cells react to estrogen and progesterone hormones. |
| Grade | Looks at how much the cancer cells look like normal cells. This tells us how aggressive the cancer is. |
| Margins | Checks if cancer cells are on the edges of the tissue sample. This helps plan surgery. |
These steps and tests help make a treatment plan for patients with invasive lobular carcinoma HER2 negative.
Staging of Lobular Carcinoma
Staging is key to understanding lobular carcinoma. It shows how far the cancer has spread. The process looks at several things to find the right stage, from stage I to stage IV. Each stage has its own features, which help make a treatment plan just for you.
Stages of Lobular Breast Cancer
Lobular carcinoma has four main stages:
- Stage I: Cancer is in the breast and is small, up to 2 centimeters wide.
- Stage II: This stage has two parts: IIA and IIB. In IIA, the tumor is 2 to 5 centimeters or has spread to a few lymph nodes. In IIB, the tumor is bigger or has spread more.
- Stage III: This stage is split into IIIA, IIIB, and IIIC. It means the cancer has spread to more lymph nodes and might be near the chest wall.
- Stage IV: This is the most advanced stage. Cancer has spread to organs like the liver, lungs, or bones.
How Staging Affects Treatment Options
Knowing the breast cancer stage is key to picking the right treatment. The treatment changes a lot from early to late stages:
- Early Stages (I & II): Surgery and radiation are common. Sometimes, hormone therapy or chemotherapy is added.
- Intermediate Stages (III): A mix of surgery, chemotherapy, radiation, and targeted treatments is used.
- Advanced Stages (IV): For cancer that has spread, treatments like chemotherapy, hormone therapy, and targeted therapy are given.
The lobular carcinoma staging is crucial for doctors to make the best treatment plan. It looks at the tumor size and spread. This way, the right treatment based on cancer stage can be found. It helps improve the patient’s chances and life quality.
Treatment Options for HER2 Negative Invasive Lobular Carcinoma
There are many ways to treat HER2 negative invasive lobular carcinoma. These include surgery, radiation, chemotherapy, targeted therapy, and immunotherapy. It’s important to know about these treatments to get the best results.
Surgical Treatment
Surgery is a key part of treating breast cancer. There are two main surgeries: lumpectomy and mastectomy. Lumpectomy removes the cancer but keeps the breast. Mastectomy takes out the whole breast.
It’s important to talk to your doctor about which surgery is right for you. This depends on how advanced the cancer is.
Radiotherapy and Chemotherapy
After surgery, radiation is often used to kill any cancer cells left behind. Chemotherapy uses drugs to destroy cancer cells. It can be given through the bloodstream or directly to the area.
For HER2 negative invasive lobular carcinoma, chemotherapy helps shrink the tumor and fight cancer cells that have spread.
Targeted Therapy and Immunotherapy
Targeted therapy targets specific cancer cells without harming healthy ones. It’s a good choice for HER2 negative cases. Immunotherapy uses the body’s immune system to fight cancer. These newer treatments offer hope and should be part of your treatment plan.
Prognosis of Lobular Carcinoma
The prognosis of HER2 negative invasive lobular carcinoma depends on many factors. These factors are key for patients and doctors to know.
Factors Affecting Prognosis
Many predictive factors in cancer prognosis affect patients with lobular carcinoma. These include:
- Stage at Diagnosis: Finding cancer early usually means a better lobular carcinoma prognosis. Cancer found later often has worse outcomes.
- Age: Younger people usually have better survival rates for breast cancer than older ones.
- Response to Treatment: How well treatments like surgery, chemo, and radiation work greatly affects the prognosis.
- Molecular and Genetic Markers: Certain biomarkers show how aggressive the cancer is and how it might react to treatment.
Long-term Survival Rates
Looking at long-term survival rates for breast cancer, we see how different factors work together:
| Stage at Diagnosis | 5-Year Survival Rate |
|---|---|
| Stage I | 95% |
| Stage II | 85% |
| Stage III | 70% |
| Stage IV | 25% |
The lobular carcinoma prognosis depends a lot on these factors. Early diagnosis means better survival rates. This shows why regular checks and catching cancer early are so important.
Understanding HER2 Negative Breast Cancer
Breast cancer is classified based on the HER2 protein. This protein helps some cancer cells grow. Knowing about HER2 negative receptor status is key to understanding this type of cancer and how to treat it.
HER2 Protein and Its Role in Breast Cancer
HER2, or human epidermal growth factor receptor 2, is very important in biology of her2 negative cancer. In HER2 positive cancers, these receptors make cancer cells grow and spread. But HER2 negative breast cancers don’t have these receptors. This means they don’t need HER2 to grow.
This difference changes how the cancer acts and how it should be treated.
Why Being HER2 Negative Matters
The importance of her2 in treatment is clear when we look at breast cancer treatments. HER2 positive cancers work well with targeted treatments like trastuzumab (Herceptin). But HER2 negative cancers don’t need these treatments. They might get hormone therapy, chemotherapy, or other treatments based on their biology.
| Comparison | HER2 Positive | HER2 Negative |
|---|---|---|
| Receptor Status | Overexpressed | Absent |
| Response to Trastuzumab | Effective | Ineffective |
| Treatment Options | Targeted Therapy | Hormone Therapy, Chemotherapy |
Risk Factors for Lobular Breast Cancer
Lobular breast cancer is less common but still a big health issue. Knowing the causes of lobular breast cancer helps us prevent it and find it early. These causes include hereditary and environmental factors.
Hereditary Factors
Many lobular breast cancers come from hereditary factors. Mutations in genes like BRCA1 and BRCA2 make getting this cancer more likely. If your family has breast cancer, you’re at higher risk. This shows why genetic tests and advice are key.
Environmental Risk Factors
Things around us also affect lobular breast cancer risk. Drinking too much alcohol, smoking, and eating poorly can increase your risk. Also, using hormone replacement therapy (HRT) and some beauty products can raise your risk.
| Risk Factor Type | Examples | Impact |
|---|---|---|
| Hereditary Factors | BRCA1/BRCA2 mutations, family history | High risk |
| Environmental Risk Factors | Lifestyle choices (smoking, alcohol), HRT, endocrine disruptors | Moderate to high risk |
Knowing and lowering these risks can help your health a lot. Taking steps like getting regular check-ups and changing your lifestyle can cut your risk. Being aware of the causes of lobular breast cancer and its risks is a smart way to stay healthy.
Prevention and Early Detection
Preventing and catching breast cancer early is key. There’s no sure way to stop it, but healthy habits can help. Regular check-ups, like mammograms, are vital for finding cancer early.
Lifestyle Changes to Reduce Risk
Living a healthy life can lower your risk. This means staying active, eating well, and drinking less. Quitting smoking helps a lot too. Keeping a healthy weight is also important since being overweight increases risk.
Importance of Regular Screening
Following screening guidelines is crucial for finding cancer early. Mammograms are a key tool for this. Women should start mammograms at age 40, as advised by their doctor. Self-checks and doctor exams help spot any breast changes early.
By making healthy choices and getting regular check-ups, you can help prevent breast cancer. Knowing about breast health and staying alert can really help catch cancer early.
FAQ
What is HER2 Negative Invasive Lobular Carcinoma?
HER2 Negative Invasive Lobular Carcinoma is a type of breast cancer. It doesn't have the HER2 protein. This makes treatment choices and outcomes different from HER2 positive types.
How is HER2 Negative Breast Cancer different from other subtypes?
This type of breast cancer doesn't have the HER2 protein. So, it doesn't react to treatments like trastuzumab (Herceptin). This means different treatments are needed, affecting treatment and how well the patient does.
What symptoms are associated with lobular carcinoma?
Early signs include changes in breast feel and feeling full or thick in one area. Later, the breast may change shape or size more obviously.
ACIBADEM Healthcare Group Hospitals and Clinics
With a network of hospitals and clinics across 5 countries, including 40 hospitals, ACIBADEM Healthcare Group has a global presence that allows us to provide comprehensive healthcare services to patients from around the world. With over 25,000 dedicated employees, we have the expertise and resources to deliver unparalleled healthcare experiences. Our mission is to ensure that each patient receives the best possible care, supported by our commitment to healthcare excellence and international healthcare standards. Ready to take the first step towards a healthier future? Contact us now to schedule your Free Consultation Health session. Our friendly team is eager to assist you and provide the guidance you need to make informed decisions about your well-being. Click To Call Now!*The information on our website is not intended to direct people to diagnosis and treatment. Do not carry out all your diagnosis and treatment procedures without consulting your doctor. The contents do not contain information about the therapeutic health services of Acıbadem Health Group.
